2025.08.26
On August 25, 2025, the Science and Technology Commission of Qingpu District, Shanghai, officially released the “Public Notice on Enterprises Advancing to the Semifinals of the Qingpu Division of the 2025 ‘Innovation·Shanghai’ International Innovation and Entrepreneurship Competition.” Relying on its technological strength and innovative potential in the field of antibody drug development, Shanghai Constream biotechnology Co., Ltd. stood out among numerous participating enterprises and was successfully selected for the semifinalist list (listed as item 20 in the attachment, belonging to the Startup Group), marking official recognition of the company’s technological direction and development prospects.
2025.08.13
The Asia BIO Innovation Summit 2025 is one of the most influential industry events in Asia, with a strong focus on two cutting-edge fields: antibody–drug conjugates (ADCs) and cell and gene therapies (CGTs). The summit aims to establish an academic exchange platform, enabling leading ADC and CGT companies from Asia and around the world to showcase their latest technologies and research findings, while fostering in-person international technical exchanges and facilitating business collaboration opportunities.
2025.06.10
Monoclonal antibodies, owing to their high specificity and strong affinity for antigens, have become the predominant class in antibody‑drug development. However, as research has advanced, their limitations have become increasingly apparent, including a finite number of antigen‑binding events and the potential to trigger unintended antibody clearance and antigen accumulation effects.
2025.06.05
On May 29–30, 2025, the “CGCS 2025 Sixth International China Summit and Exhibition on Cell and Gene Therapy,” hosted by Chujie Bio, was grandly held at the Nanjing Yangtze River International Convention Center. Shanghai Xichang Bio, a key player in the cell and gene therapy (CGT) sector, attended this major industry event, engaging with global experts and industry leaders to discuss cutting-edge trends.
2025.06.06
Through analysis of human kidney gene expression and methylation patterns, the authors found that the CHAC1 gene, located on chromosome 15 and encoding glutathione-specific γ-glutamyltransferase 1, is influenced by genetic variants associated with kidney disease in genome-wide association studies (GWAS).
2025.05.23
“Target” Seizes the Initiative | A New Antiviral Target, SAMD9, Has Been Discovered!
Double-stranded DNA (dsDNA) or double-stranded RNA (dsRNA) originating from microorganisms or endogenous sources can be recognized by the cell’s innate immune system, triggering an immune response.
2025.05.16
“Targeting” the Lead: The Key Target GHS‑R1a Marks a New Breakthrough in Anxiety Disorder Treatment!
Anxiety disorders are a mental illness that affects hundreds of millions of people worldwide, yet existing treatments have limited efficacy and significant side effects.
2025.05.21
On May 16, under a gentle breeze and dappled clouds, all members of our company set out together for Zhouzhuang Ancient Town, renowned as “China’s First Water Town.”
26
2025
/
08
13
2025
/
08
10
2025
/
06
05
2025
/
06
06
2025
/
06
Subscription Information
Subscribe to receive updates from Xichang News.
Shanghai Constream biotechnology Co., Ltd
Phone:021-59255902
Address: Building 2, Floors 2–3, Lane 10688, Beiqing Road, Qingpu District, Shanghai
WeChat Official Account
Copyright © 2026 Shanghai Constream biotechnology Co., Ltd.